Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2018-04-19
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke
NCT01674790
Stepping up Aerobic Exercise to Improve Health Outcomes After Stroke
NCT02296268
Aerobic Exercise Effects on Cognitive Function in Aging Individuals
NCT06650345
Exercise, Cognitive Function and Neuroplasticity in Healthy Adults
NCT02994134
Home-based Circuit Training for People With Intermittent Claudication
NCT05059899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aerobic exercise
aerobic exercise
40 minutes of aerobic exercise, twice per week for six weeks.
Sessions comprised of the following: 10-minute warm-up, 40-minute conditioning period as a circuit, and 10-minute cool-down.
Aerobic exercises (for example, recumbent cycling, stepping, arm crank) commenced at an intensity of 40-50% heart rate reserve (HRR) and increased incrementally by 10% as tolerated, up to a maximum of 70-80%. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.
Resistance exercise
Resistance exercise
4 x resistance exercises (3 sets of 6 repetitions), twice per week for six weeks.
Strengthening exercises (for example, resistance band work) were prescribed at an intensity that corresponded to 11-12 and incrementally increased to a maximum of 14-15, as tolerated, on the Borg Ratings of Perceived Exertion (RPE) 6-20 Scale. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance exercise
4 x resistance exercises (3 sets of 6 repetitions), twice per week for six weeks.
Strengthening exercises (for example, resistance band work) were prescribed at an intensity that corresponded to 11-12 and incrementally increased to a maximum of 14-15, as tolerated, on the Borg Ratings of Perceived Exertion (RPE) 6-20 Scale. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.
aerobic exercise
40 minutes of aerobic exercise, twice per week for six weeks.
Sessions comprised of the following: 10-minute warm-up, 40-minute conditioning period as a circuit, and 10-minute cool-down.
Aerobic exercises (for example, recumbent cycling, stepping, arm crank) commenced at an intensity of 40-50% heart rate reserve (HRR) and increased incrementally by 10% as tolerated, up to a maximum of 70-80%. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are aged \>18 years,
* Are more than 6 months post-stroke,
* Score 2-3 on the Functional Ambulation Category
* Can follow 1-stage commands i.e. sufficient communication/orientation for interventions in the trial.
Exclusion Criteria
* A previous diagnosis of dementia or any other significant cognitive decline,
* Any musculoskeletal or neurophysiological disorder preventing participation in exercise,
* Have uncontrolled hypertension, atrial fibrillation, heart failure or diabetes.
* Weigh over 250lbs/113kg (due to weight restrictions on body-weight support harness on treadmill),
* Meeting any absolute or relative contraindication to exercise from American College of Sports Medicine (ACSM)
Contraindications to Exercise 2014, see below:
Absolute contraindications to exercise:
* A recent significant change in the resting ECG suggesting significant ischaemia, recent myocardial infarction (within 2 days) or other acute cardiac event
* Unstable angina
* Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise
* Symptomatic severe aortic stenosis
* Uncontrolled symptomatic heart failure
* Actuate pulmonary embolus or pulmonary infarction
* Acute myocarditis or pericarditis
* Suspected or know dissecting aneurysm
* Acute systematic infection, accompanied by fever, body aches or swollen lymph glands
Relative contraindications to exercise:
* Left main coronary stenosis
* Moderate stenotic valvular heart disease
* Electrolyte abnormalities e.g. hypokalaemia, hypo-magnesia
* Severe arterial hypertensions i.e. systolic BP of \>200mmHg and/or diastolic BP of \>110mmHg at rest
* Tachydysrthythmia or bradydsrhythmia
* Hypertrophic cardiomyopathy and other forms of outflow tract obstruction
* Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
* High-degree atrioventricular block
* Ventricular aneurysm
* Uncontrolled metabolic disease e.g. diabetes, thyrotoxosis or myxedemia Chronic infectious diseases e.g. mononucleosis, hepatitis, AIDs
* Mental or physical impairment leading to inability to exercise adequately
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leeds Beckett University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of East Anglia
Norwich, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/EE/0409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.